BMJ publication on platelet-rich plasma injections for musculoskeletal soft tissue injuries advises against routine use in clinical practice and highlights the need for high quality research.
Scientists have found a marker that can indicate your likelihood of suffering from rheumatoid arthritis (RA) even sixteen years before the condition takes effect.
A new study led by researchers at the Kennedy Institute and published today in Immunity sheds light on the drivers behind Inflammatory bowel disease (IBD) and suggests potential new targets for treatment of the condition.
Researchers at the Kennedy Institute, part of NDORMS have repurposed the approved drug miglustat to successfully slow the progression of multiple myeloma.
By changing mouse genes to block a protein associated with obesity, researchers at the Kennedy Institute of Rheumatology, NDORMS have prevented fat from forming around the animals' internal organs, even when the animals eat an unhealthy diet. The study in Nature Medicine found that these genetically engineered mice also retained their sensitivity to insulin (normally blunted by obesity), despite gaining weight.
New research published today in eLife demonstrates a new function for Wiskott-Aldrich Syndrome (WAS) protein in the activation of T cells, which play a central role in our immune system.
New guidelines aiming to improve tools used by doctors in making diagnoses and treatment decisions are published today in the Annals of Internal Medicine and 10 other journals.
![\"Csm](\"https://www.ndorms.ox.ac.uk/news/csm-and-rrio-researchers-shine-a-spotlight-on-the-quality-of-fall-prevention-research/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n